Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.
Filetype[PDF-1.44 MB]


Details:
  • Supporting Files:
    No Additional Files

You May Also Like: